Correlation Between Bioatla and C4 Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bioatla and C4 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bioatla and C4 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bioatla and C4 Therapeutics, you can compare the effects of market volatilities on Bioatla and C4 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bioatla with a short position of C4 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bioatla and C4 Therapeutics.

Diversification Opportunities for Bioatla and C4 Therapeutics

0.71
  Correlation Coefficient

Poor diversification

The 3 months correlation between Bioatla and CCCC is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Bioatla and C4 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on C4 Therapeutics and Bioatla is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bioatla are associated (or correlated) with C4 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of C4 Therapeutics has no effect on the direction of Bioatla i.e., Bioatla and C4 Therapeutics go up and down completely randomly.

Pair Corralation between Bioatla and C4 Therapeutics

Given the investment horizon of 90 days Bioatla is expected to under-perform the C4 Therapeutics. In addition to that, Bioatla is 1.52 times more volatile than C4 Therapeutics. It trades about -0.22 of its total potential returns per unit of risk. C4 Therapeutics is currently generating about -0.17 per unit of volatility. If you would invest  364.00  in C4 Therapeutics on November 30, 2024 and sell it today you would lose (93.00) from holding C4 Therapeutics or give up 25.55% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Bioatla  vs.  C4 Therapeutics

 Performance 
       Timeline  
Bioatla 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Bioatla has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
C4 Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days C4 Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in March 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Bioatla and C4 Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bioatla and C4 Therapeutics

The main advantage of trading using opposite Bioatla and C4 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bioatla position performs unexpectedly, C4 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in C4 Therapeutics will offset losses from the drop in C4 Therapeutics' long position.
The idea behind Bioatla and C4 Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios